Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-10-01FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Fenofibrate submitted by Lupin Pharmaceuticals, Inc., indicating a regulatory change to this…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma
A clinical trial investigating whether high-speed centrifugation improves measurement of anti-Xa activity in lipemic plasma from individuals…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Response to an Intervention With Omega-3 (RIO - Study) [NA]
This document provides a status update on a completed clinical trial (RIO - Study) evaluating an Omega-3 intervention for individuals who ar…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers [Phase 1]
Phase 1 clinical trial update reports completion of a Phase 1 study of VSA003 in Chinese adult healthy volunteers.
-
FDA approval · 2025-08-28FDA Approved: FENOFIBRATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for fenofibrate, authorizing continued marketing of fenofibrate for lipid-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-08-21FDA Approved: FENOFIBRATE — Supplemental Application (AvKARE)
FDA approved a supplemental application for Fenofibrate by AvKARE. This approval supports the generic product's marketing under an approved …
-
FDA approval · 2025-08-21FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for fenofibrate filed by Cipla USA Inc. under the ANDA 208709.
-
FDA approval · 2025-08-21FDA Approved: FENOFIBRATE — Supplemental Application (Creekwood Pharmaceuticals LLC)
FDA approved a supplemental application for fenofibrate submitted by Creekwood Pharmaceuticals LLC. The action represents an approved regula…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of the ezetimibe/rosuvastatin combination (EzetimiBe/Rosuvastatin) in patients w…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of pegozafermin in individuals with severe hypertriglyceridemia; the study is curr…
-
FDA approval · 2025-08-06FDA Approved: ICOSAPENT ETHYL — Original Application (Vitruvias Therapeutics, Inc.)
FDA approved the original application for ICOSAPENT ETHYL by Vitruvias Therapeutics, Inc., enabling a generic version of the triglyceride-lo…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation [NA]
A clinical trial is evaluating whether curcumin and astaxanthin can lower triglyceride levels and inflammatory markers; the study is current…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Culturally Adapted Dietary Clinical Trial in PR [NA]
A clinical trial in Puerto Rico is recruiting to evaluate a culturally adapted dietary intervention for adults with type 2 diabetes and obes…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Evaluation of the Efficacy of Phospholipid-Bound Omega-3 Versus Omega-3 Alone in Patients With Hypertriglyceridemia: A Randomized Clinical Trial [NA]
A randomized clinical trial comparing phospholipid-bound omega-3 to omega-3 alone for lowering triglycerides in patients with hypertriglycer…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis [Phase 1]
A Phase 1 safety study of a gene therapy drug for familial hypertriglyceridemia with recurrent pancreatitis is currently recruiting.
-
FDA approval · 2025-06-06FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approves a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia [Phase 1]
A Phase 1 study of LY3875383 in healthy participants and individuals with hypertriglyceridemia has been terminated.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol [NA]
This entry updates the status of a clinical trial evaluating the cardiometabolic effects of omega-3 fatty acids functionalized with hydroxyt…
-
FDA approval · 2025-05-22FDA Approved: FENOFIBRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for fenofibrate (generic) under ANDA 201748, authorizing the mar…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Vitamin C Administration and Triglycerides Level in Critical Care Patients
This clinical trial from Meir Medical Center is investigating whether vitamin C administration affects triglyceride levels in critically ill…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Barberry and Cardiometabolic Risk Factors in Individuals With Hypertriglyceridemia [NA]
A completed clinical trial evaluating the effects of Barberry on cardiometabolic risk factors in individuals with hypertriglyceridemia.
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia [Phase 2]
A Phase 2 study comparing NST-1024 to placebo to assess efficacy and safety in subjects with hypertriglyceridemia has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Trial to Assess Full-fat or Low-fat Dairy Foods on Insulin Sensitivity, RBC FA's and Other Markers of Metabolic Health [NA]
This clinical trial compared full-fat versus low-fat dairy foods on insulin sensitivity and other metabolic health markers in adults with ov…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD [Phase 2]
Phase 2a clinical trial update evaluating the safety, tolerability, and efficacy of TLC-2716 in adults with hypertriglyceridemia and nonalco…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects [NA]
This ClinicalTrials.gov entry describes a study evaluating the effects of DHA-NAT on postprandial lipemia in healthy male subjects, and the …